Literature DB >> 20564321

New prospective for non-invasive detection, grading, size evaluation, and tumor location of prostate cancer.

M Cortesi1, E Fridman, A Volkov, S Sh Shilstein, R Chechik, A Breskin, D Vartsky, G Raviv, J Ramon.   

Abstract

BACKGROUND: PSA blood test and other present screening tools fail to provide the required sensitivity and specificity and, at early stages, lack correlation with tumor grade, volume, and location. Thus alternative approaches are highly desired. We present and assess a novel method for PCa detection, grading, volume evaluation and tumor location, based on non-invasive zinc concentration mapping in the gland by means of a dedicated rectal probe.
METHODS: Zinc-concentration values measured in histologically examined tissue fragments from needle biopsy of 598 patients were analyzed. They were used to generate computer simulated zinc-concentration maps, further analyzed with image-processing tools. The tumor detection performances versus Gleason grade were assessed.
RESULTS: A significant increase of zinc depletion with increasing Gleason pattern (grade) classification was established. Tumor detection performance in zinc-concentration maps progressively improves with the cancer's first component score. Reliable information on the location, size and Gleason-grade combination of the lesion can be extracted for clinically relevant volumes.
CONCLUSIONS: Zinc depletion in the prostate peripheral zone is the basis for a novel, non-invasive PCa detection, localization, volume evaluation and grading method. Its realization and application as a pre-biopsy and pre-treatment examination, or a follow-up tool, relies on the development of a dedicated transrectal probe. It should have significant impact on biopsy effectiveness, point at a possible extraprostatic extension and provide critical data for focal treatment. The information on tumor grade and distribution may have an important impact on disease management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564321     DOI: 10.1002/pros.21205

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  3 in total

1.  Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.

Authors:  R Dittrich; J Kurth; E A Decelle; E M DeFeo; M Taupitz; S Wu; C-L Wu; W S McDougal; L L Cheng
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-01-31       Impact factor: 5.554

2.  Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report.

Authors:  Jin Zhang; Mei Dong; Xiaolei Hu; Lin Liu; Shen Li; Chao Li; Lijun Yang; Yongqiang Xiao; Shujian Pang; Chuan Wang
Journal:  Oncol Lett       Date:  2015-11-16       Impact factor: 2.967

Review 3.  Zinc transporters in prostate cancer.

Authors:  M-C Franz; P Anderle; M Bürzle; Y Suzuki; M R Freeman; M A Hediger; G Kovacs
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.